242 related articles for article (PubMed ID: 22419875)
1. Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.
Ma X; Wang H; Jin S; Wu Y; Liang XJ
Int J Nanomedicine; 2012; 7():1313-28. PubMed ID: 22419875
[TBL] [Abstract][Full Text] [Related]
2. Construction of nanoparticles based on amphiphilic copolymers of poly(γ-glutamic acid co-L-lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine as a potential drug delivery carrier.
Liu X; Su S; Wei F; Rong X; Yang Z; Liu J; Li M; Wu Y
J Colloid Interface Sci; 2014 Jan; 413():54-64. PubMed ID: 24183430
[TBL] [Abstract][Full Text] [Related]
3. Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery.
Han S; Li M; Liu X; Gao H; Wu Y
Colloids Surf B Biointerfaces; 2013 Feb; 102():833-41. PubMed ID: 23107962
[TBL] [Abstract][Full Text] [Related]
4. Construction of amphiphilic copolymer nanoparticles based on hyperbranched poly (amine-ester) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine as drug carriers for cancer therapy.
Wu Y; Jiao F; Han S; Fan T; Liu Y; Li W; Hu L; Zhao Y; Chen C
Nanomedicine; 2011 Dec; 7(6):945-54. PubMed ID: 21664985
[TBL] [Abstract][Full Text] [Related]
5. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
[TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y
Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775
[TBL] [Abstract][Full Text] [Related]
8. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
9. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
10. Curcumin loaded poly(2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid--in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells.
Kumar SS; Surianarayanan M; Vijayaraghavan R; Mandal AB; MacFarlane DR
Eur J Pharm Sci; 2014 Jan; 51():34-44. PubMed ID: 24012589
[TBL] [Abstract][Full Text] [Related]
11. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
13. Preparation of colloidal nanoparticles PVA-PHEMA from hydrolysis of copolymers of PVAc-PHEMA as anticancer drug carriers.
Shahrousvand M; Hajikhani M; Nazari L; Aghelinejad A; Shahrousvand M; Irani M; Rostami A
Nanotechnology; 2022 Apr; 33(27):. PubMed ID: 35320784
[TBL] [Abstract][Full Text] [Related]
14. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
15. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
17. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
[TBL] [Abstract][Full Text] [Related]
18. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.
Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS
Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442
[TBL] [Abstract][Full Text] [Related]
19. Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies.
Adesina SK; Holly A; Kramer-Marek G; Capala J; Akala EO
J Pharm Sci; 2014 Aug; 103(8):2546-55. PubMed ID: 24961596
[TBL] [Abstract][Full Text] [Related]
20. Feedback-regulated paclitaxel delivery based on poly(N,N-dimethylaminoethyl methacrylate-co-2-hydroxyethyl methacrylate) nanoparticles.
You JO; Auguste DT
Biomaterials; 2008 Apr; 29(12):1950-7. PubMed ID: 18255142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
